Farther Finance Advisors, LLC Verve Therapeutics, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 2,477 shares of VERV stock, worth $27,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,477
Previous 28
8746.43%
Holding current value
$27,643
Previous $116,000
23880.17%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERV
# of Institutions
201Shares Held
79.5MCall Options Held
204KPut Options Held
101K-
Alphabet Inc. Mountain View, CA12.3MShares$138 Million5.03% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$77 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.6 Million2.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$44.1 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $669M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...